Home/All Molecules/Sodium Alginate

Sodium Alginate Range

Comprehensive Sodium Alginate portfolio for Franchise & Manufacturing.

Category
sodium-alginate
Total Formulations
2
Available Forms
Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Sodium Alginate portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Sodium Alginate batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Sodium Alginate PCD Pharma Franchise Company

Sodium Alginate PCD Pharma Franchise Company

Cafoli Lifecare offers a Sodium Alginate PCD pharma franchise backed by 2 formulations in syrup and tablet form. Though a compact range, it is a focused anti-reflux offering manufactured at WHO-GMP certified facilities with DCGI-approved compositions, ideal for partners building a gastroenterology portfolio.

What is Sodium Alginate?

Sodium alginate is the sodium salt of alginic acid, a natural polysaccharide obtained from brown seaweed. On contact with gastric acid it precipitates into a gel and forms a low-density “raft” that floats on the stomach contents, physically preventing acid and stomach contents from refluxing into the oesophagus. Unlike acid suppressants it does not alter gastric acid secretion. Compound information is catalogued on PubChem.

Therapeutic Applications of Sodium Alginate

Sodium alginate is used for symptomatic relief of gastro-oesophageal reflux disease (GERD), heartburn, acid regurgitation and dyspepsia, including reflux symptoms during pregnancy and reflux-related laryngopharyngeal complaints. It is prescribed by gastroenterologists, ENT surgeons, general physicians, obstetricians and paediatricians.

Why Sodium Alginate is a High-Potential Molecule for Distributors

Alginates occupy a niche that acid suppressants cannot fill. Because the raft forms within minutes, patients feel relief far faster than with a PPI, which is exactly why clinicians add an alginate on top of PPI therapy rather than replacing it — the two sell together instead of cannibalising each other. Its non-systemic, mechanical mode of action also makes it one of the few reflux treatments commonly used in pregnancy, giving a distributor access to obstetric prescribers who are otherwise cautious with gastro drugs. With reflux prevalence climbing alongside urban dietary change, this remains an under-served, high-margin niche.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers genuine district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and complete promotional inputs including visual aids, samples, prescription pads and MR bags. We are trusted by 1000+ franchise partners across India.

References

  1. PubChem – Sodium Alginate compound record
  2. MedlinePlus – Sodium Alginate information
  3. PubMed – clinical literature on Sodium Alginate

Aceclofenac in Modern Clinical Practice

Our formulations of Sodium Alginate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Sodium Alginate in PCD Franchise

Start Your Sodium Alginate Franchise with Cafoli Lifecare

Ready to build your own Sodium Alginate distribution business? Cafoli Lifecare offers monopoly-based PCD pharma franchise rights, WHO-GMP certified manufacturing and complete promotional support. Call 9518447302 or email info@cafoli.in to check district availability and receive our latest price list.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare currently lists 2 Sodium Alginate formulations, available as a syrup and a tablet. Composition, packing and pricing details are shared with prospective partners on enquiry.

Yes. Sodium Alginate is offered on a district monopoly basis, so only one Cafoli franchise partner is appointed per territory, subject to verification of your Drug License.

Sodium Alginate is prescribed by gastroenterologists and ENT specialists, and by general physicians, obstetricians and paediatricians managing acid reflux and heartburn.

Alginates act mechanically by forming a raft over the stomach contents rather than suppressing acid, so they work within minutes and are used alongside PPIs rather than instead of them. That complementary role matters commercially: they are also one of the few reflux options widely considered suitable in pregnancy, which opens an obstetrics prescribing channel that acid suppressants do not reach.

A valid Drug License and GST registration number are required to begin the appointment process with Cafoli Lifecare.